30 Dec
2020

The biggest life sciences IP stories of 2020

Pharma patent rights were at the forefront of policy discussions this year, thanks to the coronavirus pandemic. However, as IAM’s life sciences reporter Adam Houldsworth explains, they were not the only game in town

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth